NDT comprises three R&D divisions


•Molecular Therapeutics Division (MTD)
Development of novel targeted therapies for clinical unmet needs in niche biomedical market


•Advanced Technology Center (ADT)
Developing nanoscale, organic, inorganic and hybrid materials; commercializing the technologies for various applications


•Life Science Research Center (LSC)
Developing novel active transdermal technology for the delivery of therapeutics and vaccines


http://www.ndtcorp.com/